Bristol scientist puts the brakes on breast cancer

Why do breast cells grow out of control?  The answer could be a step closer thanks to a grant of around £200,000 from one of the UK's leading breast cancer research charities, Breast Cancer Campaign, to University of Bristol scientist, Dr Claire Perks.

The grant forms part of £2.3 million awarded to 20 projects around the UK and will fill one of the research gaps identified by the countries top breast cancer experts in a recent study carried out by the charity.

Breast tumours form when breast cells grow out of control. Although the body has systems in place to try and prevent this from happening often in breast cancer these no longer work.

A protein called PTEN normally acts as a brake to stop normal cells in the body growing out of control. However if the PTEN brake stops working, the breast cells can multiply and turn cancerous. 

With previous Breast Cancer Campaign funding Dr Perks discovered another protein called IGFBP-2, also found in breast cells, stops PTEN from doing its job, allowing breast cells to grow without the normal control system in place. 

Dr Perks, Senior Research Fellow in the IGF and Metabolic Endocrinology group based in the Department of Clinical Science at North Bristol, said: "With my project grant I will study breast cancer cells in the laboratory to gain a better understanding of the interaction between PTEN and IGFBP-2 and their effect on breast cells."

Pamela Goldberg, Chief Executive, Breast Cancer Campaign said: "When more is known about the relationship between PTEN and IGFBP-2 it will help scientists to develop new treatments to restore the protective function of PTEN, resulting in an entirely new way of treating breast cancer."

Please contact Joanne Fryer for further information.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-powered tool predicts gene activity in cancer cells from biopsy images